Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAXIBOTULINUMTOXIN A-LANM vs DEFERIPRONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAXIBOTULINUMTOXIN A-LANM vs DEFERIPRONE: Safety Overview

Metric DAXIBOTULINUMTOXIN A-LANM DEFERIPRONE
Total FAERS Reports 891 2,487
Deaths Reported 0 287
Death Rate N/A 11.5%
Hospitalizations 5 923
Average Patient Age 43.1 yrs 41.7 yrs
% Female Patients 97.3% 57.4%
FDA Approval Date N/A Apr 20, 2018
Manufacturer N/A Chiesi USA, Inc.
Route N/A ORAL
Marketing Status N/A Prescription